Barclays PLC Jazz Pharmaceuticals PLC Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Barclays PLC holds 39,210 shares of JAZZ stock, worth $4.76 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

39,210

Previous 39,210 -0.0%

Holding current value

$4.76 Million

Previous $4.37 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$100.57 - $116.37 $632,484 - $731,850	6,289 Added 19.1%	39,210 $4.37 Million
Q2 2024 Aug 14, 2024	SELL	$103.94 - $118.98 $6.77 Million - $7.75 Million	-65,135 Reduced 66.43%	32,921 $3.51 Million
Q1 2024 May 15, 2024	SELL	$115.19 - $132.77 $1.18 Million - $1.37 Million	-10,285 Reduced 9.49%	98,056 $11.8 Million
Q4 2023 Feb 15, 2024	BUY	$114.26 - $136.0 $1.03 Million - $1.22 Million	8,975 Added 9.03%	108,341 $13.3 Million
Q3 2023 Nov 07, 2023	BUY	$122.0 - $145.31 $1.08 Million - $1.28 Million	8,834 Added 9.76%	99,366 $12.9 Million
Q2 2023 Aug 03, 2023	BUY	$122.5 - $147.16 $2.92 Million - $3.51 Million	23,851 Added 35.77%	90,532 $11.2 Million
Q1 2023 May 04, 2023	SELL	$133.98 - $160.47 $839,786 - $1.01 Million	-6,268 Reduced 8.59%	66,681 $9.76 Million
Q4 2022 Feb 13, 2023	BUY	$129.72 - $159.85 $3.82 Million - $4.71 Million	29,462 Added 67.75%	72,949 $11.6 Million
Q3 2022 Nov 03, 2022	BUY	$126.59 - $161.18 $301,031 - $383,286	2,378 Added 5.78%	43,487 $5.8 Million
Q2 2022 Aug 12, 2022	BUY	$141.59 - $168.66 $654,570 - $779,715	4,623 Added 12.67%	41,109 $6.41 Million
Q1 2022 May 16, 2022	SELL	$129.64 - $160.7 $5.05 Million - $6.26 Million	-38,975 Reduced 51.65%	36,486 $5.68 Million
Q4 2021 Feb 14, 2022	SELL	$119.87 - $145.67 $2.57 Million - $3.13 Million	-21,472 Reduced 22.15%	75,461 $9.61 Million
Q3 2021 Nov 09, 2021	BUY	$128.64 - $184.79 $2.23 Million - $3.2 Million	17,327 Added 21.77%	96,933 $12.6 Million
Q2 2021 Aug 13, 2021	BUY	$160.2 - $186.42 $5.08 Million - $5.91 Million	31,729 Added 66.27%	79,606 $14.1 Million
Q1 2021 May 13, 2021	BUY	$150.19 - $173.5 $2.32 Million - $2.68 Million	15,469 Added 47.73%	47,877 $7.87 Million
Q4 2020 Feb 11, 2021	SELL	$140.71 - $165.05 $463,076 - $543,179	-3,291 Reduced 9.22%	32,408 $5.35 Million
Q3 2020 Nov 12, 2020	SELL	$105.46 - $144.13 $2.22 Million - $3.04 Million	-21,093 Reduced 37.14%	35,699 $5.09 Million
Q2 2020 Aug 12, 2020	SELL	$95.68 - $121.88 $940,056 - $1.2 Million	-9,825 Reduced 14.75%	56,792 $6.27 Million
Q1 2020 May 13, 2020	SELL	$87.74 - $152.74 $4.01 Million - $6.98 Million	-45,702 Reduced 40.69%	66,617 $6.64 Million
Q4 2019 Feb 10, 2020	BUY	$117.65 - $153.73 $3.36 Million - $4.39 Million	28,564 Added 34.1%	112,319 $16.8 Million
Q3 2019 Nov 14, 2019	BUY	$125.18 - $143.24 $2.1 Million - $2.4 Million	16,746 Added 24.99%	83,755 $10.7 Million
Q2 2019 Aug 14, 2019	BUY	$125.55 - $144.48 $1.17 Million - $1.35 Million	9,325 Added 16.17%	67,009 $9.55 Million
Q1 2019 May 15, 2019	SELL	$121.81 - $142.95 $1.43 Million - $1.68 Million	-11,760 Reduced 16.93%	57,684 $8.25 Million
Q4 2018 Feb 14, 2019	BUY	$115.94 - $166.74 $1.37 Million - $1.98 Million	11,851 Added 20.58%	69,444 $8.61 Million
Q3 2018 Nov 14, 2018	BUY	$161.01 - $180.57 $5.06 Million - $5.67 Million	31,413 Added 119.99%	57,593 $9.69 Million
Q2 2018 Aug 14, 2018	BUY	$146.33 - $183.18 $1.74 Million - $2.17 Million	11,857 Added 82.78%	26,180 $4.51 Million
Q1 2018 May 15, 2018	SELL	$135.59 - $157.16 $3,118 - $3,614	-23 Reduced 0.16%	14,323 $2.16 Million
Q4 2017 Feb 14, 2018	SELL	$131.06 - $150.39 $8.24 Million - $9.46 Million	-62,874 Reduced 81.42%	14,346 $1.93 Million
Q3 2017 Nov 14, 2017	BUY	$142.62 - $155.6 $11 Million - $12 Million	77,220	77,220 $11.3 Million

Others Institutions Holding JAZZ

# of Institutions

513

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.61B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account